908 Devices Inc (MASS)

Etorro trading 970x250

About 908 Devices Inc

908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in the United States, China, Japan, Europe, and internationally. The company develops its products using mass spectrometry (Mass Spec) technology, an analytical technique for molecular analysis. It offers handheld and desktop Mass Spec devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was founded in 2012 and is headquartered in Boston, Massachusetts. Address: 645 Summer Street, Boston, MA, United States, 02210

908 Devices Inc News and around…

Latest news about 908 Devices Inc (MASS) common stock and company :

908 Devices to Exhibit at ASMS and Present Key Developments in Accelerating Proteomics Workflows
27 Oct, 2021 FinancialContent

At the American Society of Mass Spectrometry (ASMS) conference October 31 to November 4 in Philadelphia, 908 Devices Inc. (Nasdaq: MASS) is presenting several talks and posters on the use of high-pressure mass spectrometry and microfluidics separation technologies to accelerate drug discovery workflows, including in metabolomics and proteomics applications. The company, a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, is also launching a new ZipChip assay kit that enables fast and accurate identification and quantitation of oligonucleotides.

12 Information Technology Stocks Moving In Monday's Intraday Session
25 Oct, 2021 FinancialContent

Gainers Vislink Technologies (NASDAQ:VISL) shares increased by 34.59% to $2.14 during Monday's regular session. As ...

908 Devices to Report Third Quarter Financial Results on November 4, 2021
21 Oct, 2021 FinancialContent

908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the third quarter 2021 before market open on Thursday, November 4, 2021. Company management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time.

Top Stock Picks of Billionaire Nicholas J. Pritzker’s Tao Capital
18 Oct, 2021 Yahoo! Finance

In this article, we discussed billionaire Nicholas J. Pritzker’s investment philosophy and his venture capital investments. We also reviewed the top stock picks of billionaire Nicholas J. Pritzker’s Tao Capital. You can skip our detailed discussion on Pritzker’s investment philosophy and top stock picks, and jump directly to the 4 Top Stock Picks of Billionaire […]

President And CEO Of 908 Devices Sold $670K In Stock
06 Oct, 2021 Yahoo! Finance

Kevin Knopp, President And CEO at 908 Devices (NASDAQ:MASS), made a large insider sell on October 1, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Knopp sold 20,000 shares of 908 Devices at prices ranging from $32.89 to $34.93. The total transaction amounted to $673,019. Knopp still owns a total of 1,278,061 shares of 908 Devices worth, $42,495,528. 908 Devices shares are trading down 1.66% at $33.25 at the ti

3 Sinking Stocks Cathie Wood Keeps Buying Anyway
03 Oct, 2021 FinancialContent

ARK Invest's founder and CEO isn't shy about averaging down on her favorite growth stocks.

Implied MOON Analyst Target Price: $45
28 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Direxion Moonshot Innovators ETF ETF (MOON), we found that the implied analyst target price for the ETF based upon its underlying holdings is $45.45 per unit.

Notable 908 Devices Insider Trades $1.90 Million In Company Stock
10 Sep, 2021 Yahoo! Finance

Joseph Griffith Iv, Chief Financial Officer at 908 Devices (NASDAQ:MASS), made a large buy and sell of company shares on September 8, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission reports that on September 8, Joseph Griffith Iv bought 49,898 908 Devices shares at prices ranging from $0.53 to $0.96 per share, for a total of $28,082. They then sold their shares on the same day in the open market at prices ranging from $36.66 to $39.0

Analysts Forecast 15% Upside For FITE
26 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— S&P Kensho Future Security ETF (FITE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $60.42 per unit.

Ultivue Announces New Independent Board Members
19 Aug, 2021 FinancialContent

Ultivue announces the addition of two independent board members, Fenel Eloi and Mary Pat Lancelotta, to help strengthen its position as a leader in advancing precision medicine solutions by accelerating tissue biomarker discovery and validation.

Bullish insiders at 908 Devices Inc. (NASDAQ:MASS) loaded up on US$1.5m of stock earlier this year
16 Aug, 2021 Yahoo! Finance

Multiple insiders secured a larger position in 908 Devices Inc. ( NASDAQ:MASS ) shares over the last 12 months. This is...

8 Best Stocks to Buy According to Billionaire Nicholas J. Pritzker’s Tao Capital
09 Aug, 2021 Yahoo! Finance

In this article, we will be discussing 8 best stocks to buy according to billionaire Nicholas J. Pritzker based on his hedge fund’s Q1 portfolio. To skip our detailed analysis of Nicholas J. Pritzker’s hedge fund returns, investment philosophy, and history, you can click to skip ahead to 4 Best Stocks to Buy According to […]

908 Devices Shares Gain On Handheld, Desktop Devices Led Q2 Revenue Beat, FY21 Guidance Above Consensus
04 Aug, 2021 FinancialContent

908 Devices Inc(NASDAQ: MASS)reported a second-quarterFY21 revenue decline of 26% year-on-year to $8.3 million, ...

908 Devices Reports Second Quarter 2021 Financial Results and Raises 2021 Revenue Outlook
04 Aug, 2021 FinancialContent

908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended June 30, 2021.

908 Devices Expands Scientific Advisory Board, Creates Dedicated Proteomics Panel
02 Aug, 2021 FinancialContent

908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the forthcoming appointment of six new individuals to its Scientific Advisory Board (SAB), including Prof. Ileana Cristea, Prof. Jennifer E. Van Eyk, Prof. Anne-Claude Gingras, Prof. Jesper Olsen, Prof. Renã Robinson, and Prof. John Yates. The new SAB members join the board’s co-chairs, Christopher D. Brown, CTO 908 Devices; and J. Michael Ramsey, Scientific Founder of 908 Devices and Professor at UNC Chapel Hill, and existing members Prof. Jarrod Marto (Dana Farber Cancer Institute/Harvard Medical School) and Prof. Josh Coon (University of Wisconsin-Madison).

908 Devices Expands Strategic Distribution Network in APAC, Europe, and the Americas
28 Jul, 2021 FinancialContent

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the expansion of its channel distribution network, adding new international traction and momentum. 908 Devices handheld and desktop devices are now available across six continents in more than 40 countries and configured in any of six languages.

Look Under The Hood: MOON Has 38% Upside
23 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Direxion Moonshot Innovators ETF ETF (MOON), we found that the implied analyst target price for the ETF based upon its underlying holdings is $44.97 per unit.

908 Devices and Transcenta’s Joint Innovation Partnership Accelerates Biopharma Development
22 Jul, 2021 FinancialContent

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced outcomes of its joint innovation partnership with Transcenta, a global biotherapeutics company. Transcenta has implemented 908 Devices’ technologies within its Process and Product Development Center and Manufacturing Facility in Hangzhou, China to facilitate their biopharma analytical workflows across large molecule characterization and formulation process development.

908 Devices to Report Second Quarter Financial Results on August 4, 2021
21 Jul, 2021 FinancialContent
Stocks That Hit 52-Week Lows On Tuesday
06 Jul, 2021 FinancialContent

Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co ...

Analysts See 10% Gains Ahead For The Holdings of VGT
22 Jun, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Information Technology ETF (VGT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $427.94 per unit.

908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights
22 Jun, 2021 FinancialContent

908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced two data analysis partnerships to integrate with the REBEL™, the first at-line fresh and spent cell media analyzer for bioprocess labs. With the integration of leading data exploratory tool Sartorius’ SIMCA® and Securecell’s Lucullus Process Information Management System (PIMS), users can seamlessly turn REBEL data into deeper actionable insights to drive operational excellence.

Mid-Morning Market Update: Markets Mixed; Kroger Earnings Top Views
17 Jun, 2021 FinancialContent

Following the market opening Thursday, the Dow traded down 0.29% to 33,935.28 while the NASDAQ rose 0.34% to 14,086.74. The S&P also ...

44 Biggest Movers From Yesterday
16 Jun, 2021 FinancialContent

Gainers Alzamend Neuro, Inc. (NASDAQ: ALZN) shares jumped 170% to close at $13.50 on Tuesday after the company priced its IPO at ...

Cathie Wood Bullish On SpaceX Partner Velo3D, Buys More SPFR Shares, Adds Vertex On Dip
13 Jun, 2021 FinancialContent

On Friday, Cathie Wood-led Ark Investment Management bought 25,000 shares, estimated to be worth about $250,000, in Jaws Spitfire Acquisition Corp, the blank-check firm that is set to take 3D printing company Velo3D public.

Cathie Wood, Bullish On SpaceX Partner Velo3D, Buys More SPFR Shares, Adds Vertex On Dip
13 Jun, 2021 FinancialContent

Cathie Wood-led Ark Investment Management on Friday bought 25,000 shares, estimated to be worth about $250,000, in Jaws Spitfire ...

908 Devices Appoints Marcia Eisenberg, Ph.D., Chief Scientific Officer of Labcorp Diagnostics, to its Board of Directors
08 Jun, 2021 FinancialContent

908 Devices (NASDAQ: MASS), a pioneer of purpose-built, handheld and desktop mass spectrometry devices for chemical and biomolecular analysis, has appointed Marcia Eisenberg, Ph.D., chief scientific officer of Labcorp Diagnostics, to serve on its Board of Directors effective immediately.

Cathie Wood Buys $10.5M In Google, Loads Up Another $31.6M In Zoom
04 Jun, 2021 FinancialContent

Cathie Wood-led Ark Investment Management on Thursday bought 4,496 shares, estimated to be worth about $10.55 million, in Google parent ...

Cathie Wood Loads Up $27.4M In Okta On Dip, Also Adds Zoom
28 May, 2021 FinancialContent

Cathie Wood-led Ark Investment Management bought 123,385 shares, estimated to be worth about $27.44 million, in Okta Inc (NASDAQ: OKTA) ...

Cathie Wood Loads Up Another $292K In SpaceX Partner Velo3D's SPAC
27 May, 2021 FinancialContent

Cathie Wood-led Ark Investment Management on Wednesday bought 29,301 shares, estimated to be worth about $292,131, in the SPACJaws ...

908 Devices Inc (MASS) is a NASDAQ Common Stock listed in , ,

970x250